NANOPARTICLES BASED COMBINED ANTIMICROBIAL DRUG DELIVERY SYSTEM AS A SOLUTION FOR BACTERIAL RESISTANCE
Hadiya, S., Ibrahem, R., Abd El-Baky, R., Elsabahy, M., Aly, S. (2022). NANOPARTICLES BASED COMBINED ANTIMICROBIAL DRUG DELIVERY SYSTEM AS A SOLUTION FOR BACTERIAL RESISTANCE. EKB Journal Management System, 45(2), 1121-1141. doi: 10.21608/bfsa.2022.271825
Safy Hadiya; Reham A Ibrahem; Rehab M Abd El-Baky; Mahmoud Elsabahy; Sherine A. Aly. "NANOPARTICLES BASED COMBINED ANTIMICROBIAL DRUG DELIVERY SYSTEM AS A SOLUTION FOR BACTERIAL RESISTANCE". EKB Journal Management System, 45, 2, 2022, 1121-1141. doi: 10.21608/bfsa.2022.271825
Hadiya, S., Ibrahem, R., Abd El-Baky, R., Elsabahy, M., Aly, S. (2022). 'NANOPARTICLES BASED COMBINED ANTIMICROBIAL DRUG DELIVERY SYSTEM AS A SOLUTION FOR BACTERIAL RESISTANCE', EKB Journal Management System, 45(2), pp. 1121-1141. doi: 10.21608/bfsa.2022.271825
Hadiya, S., Ibrahem, R., Abd El-Baky, R., Elsabahy, M., Aly, S. NANOPARTICLES BASED COMBINED ANTIMICROBIAL DRUG DELIVERY SYSTEM AS A SOLUTION FOR BACTERIAL RESISTANCE. EKB Journal Management System, 2022; 45(2): 1121-1141. doi: 10.21608/bfsa.2022.271825

NANOPARTICLES BASED COMBINED ANTIMICROBIAL DRUG DELIVERY SYSTEM AS A SOLUTION FOR BACTERIAL RESISTANCE

Bulletin of Pharmaceutical Sciences Assiut University
Volume 45, Issue 2, December 2022, Page 1121-1141  XML PDF (1.61 MB)
Document Type: Original Article
DOI: 10.21608/bfsa.2022.271825
View on SCiNiTO View on SCiNiTO
Authors
Safy Hadiya email 1; Reham A Ibrahemorcid 2; Rehab M Abd El-Baky3; Mahmoud Elsabahy4; Sherine A. Aly5
1Assiut International Center of Nanomedicine, Al-Rajhy Liver Hospital, Assiut University, Assiut 71515, Egypt
2Department of Microbiology and Immunology, Faculty of Pharmacy, Minia University, Minia 61511, Egypt
3Department of Microbiology and Immunology, Faculty of Pharmacy, Minia University, Minia 61511, Egypt -Department of Microbiology and Immunology, Faculty of Pharmacy, Deraya University, Minia 61511, Egypt
4School of Biotechnology, Badr University in Cairo, Badr City 11829, Egypt - Department of Chemistry, Texas A&M University, College Station, TX 77842, USA
5Department of Microbiology and Immunology, Faculty of Medicine, Assiut University
Abstract
The absence of novel antimicrobials is a main cause of the emergence of antibiotic resistance. Antimicrobial resistance has been evolved because of a variety of methods such as enzyme inactivation, reduced cell permeability, target mutation, changed target site/enzyme, and efflux pump overexpression. Using a combination of two antimicrobials drugs lead to an increase of the spectrum of antibiotics against multi drug resistance bacteria and a decrease in the emergence of resistant mutants. Despite of several advantages of using a combination of antibiotics, resistance can develop during treatment.  Encapsulation of antimicrobials within the nanoparticles was proven to reduce the antimicrobial resistance by increasing the intracellular bioavailability of antimicrobial drugs through decreasing the development of resistant mutants and inhibiting the efflux pump. In this review, we will summarize the antimicrobial resistance, use of combined therapy and the use of antimicrobials- loaded nanoparticles and their application in the future to fight multidrug resistant bacteria.
 
Keywords
Nanoparticles; antimicrobial resistance; antimicrobial combination; ciprofloxacin; meropenem
Statistics
Article View: 247
PDF Download: 158